Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Acquisitions & Divestments: 2015-2021

Historic Change in Acquisitions & Divestments for Anika Therapeutics (ANIK) over the last 6 years, with Mar 2021 value amounting to $2.5 million.

  • Anika Therapeutics' Change in Acquisitions & Divestments fell 83.32% to $2.5 million in Q1 2021 from the same period last year, while for Mar 2021 it was $32.5 million, marking a year-over-year decrease of 68.52%. This contributed to the annual value of $2.5 million for FY2021, which is 94.44% down from last year.
  • Latest data reveals that Anika Therapeutics reported Change in Acquisitions & Divestments of $2.5 million as of Q1 2021, which was down 86.11% from $18.0 million recorded in Q4 2020.
  • Anika Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $58.8 million for Q4 2019, and its period low was $2.5 million during Q1 2021.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $15.0 million (2020), whereas its average is $21.5 million.
  • In the last 5 years, Anika Therapeutics' Change in Acquisitions & Divestments soared by 411.06% in 2019 and then plummeted by 83.32% in 2021.
  • Over the past 5 years, Anika Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $10.2 million in 2017, then rose by 12.20% to $11.5 million in 2018, then skyrocketed by 411.06% to $58.8 million in 2019, then crashed by 69.37% to $18.0 million in 2020, then crashed by 83.32% to $2.5 million in 2021.
  • Its Change in Acquisitions & Divestments stands at $2.5 million for Q1 2021, versus $18.0 million for Q4 2020 and $7.0 million for Q3 2020.